{"id":"bezlotoxumab-injection-zinplava","safety":{"commonSideEffects":[{"rate":"10.4","effect":"Nausea"},{"rate":"9.4","effect":"Diarrhea"},{"rate":"7.2","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Bezlotoxumab is a monoclonal antibody that targets and neutralizes Clostridioides difficile toxins A and B, preventing them from causing disease.","oneSentence":"Inhibits Clostridioides difficile toxin","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:23:27.590Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of Clostridioides difficile infection recurrence"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Bezlotoxumab Injection [Zinplava]","genericName":"Bezlotoxumab Injection [Zinplava]","companyName":"Fundacion SEIMC-GESIDA","companyId":"fundacion-seimc-gesida","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Inhibits Clostridioides difficile toxin Used for Prevention of Clostridioides difficile infection recurrence.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}